Atlas Trials

Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma

Clinical trial NCT02242929 · UNKNOWN

Trial details

NCT number
NCT02242929
Sponsor
Maastricht University Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Nodular Basal Cell Carcinoma
Start date
2016-01-01
Primary completion
2017-12-01
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.